Australia's most trusted
source of pharma news
|Alyssa Kent at her 40th birthday|
Posted 9 July 2021 AM
The Australian pharma industry has rallied to support Gilead senior business unit director Alyssa Kent who suffered a blood clot to the brain after having the AstraZeneca COVID-19 vaccine, leaving her in a coma for two weeks and close to death.
The popular 40-year-old married mother of two spent three weeks in ICU, with her family forced to make "end of life choices" three times.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.